Abstract

Onion is one of the most commonly used plants in the traditional medicine for the treatment of various diseases. We recently demonstrated the anti-inflammatory properties of onion bulb extract (OBE) in reducing colitis severity in mice when administered at the same time of colitis induction. However, whether onion can reverse established colitis or even prevent its development has not been investigated. To test 1. whether OBE can reduce colitis severity when given either before (preventative approach) or after (treatment approach) colitis induction and if so, 2. what are the mechanisms by which onion can achieve these effects. Colitis was induced by dextran sulfate sodium (DSS) administration using treatment and preventative approaches. The severity of the inflammation was determined by the gross and histological assessments. The colonic level/activity of pro-inflammatory molecules and immune cell markers was assessed by immunofluorescence and western blotting analysis. In vitro neutrophil superoxide release and survival was assessed by chemilumenecense and Annexin-V/7AAD assays respectively. OBE treatment significantly reduced colitis severity in both approaches, the colonic expression/activity profile of pro-inflammatory molecules, inhibited WKYMVm-induced superoxide release, and increased spontaneous apoptosis of neutrophils in vitro. OBE can be used as an effective option in the prevention and/or the treatment of established colitis.

Highlights

  • Inflammatory bowel disease (IBD) is a bacterially-triggered chronic inflammatory condition of the gastrointestinal tract in a genetically susceptible host [1,2,3,4]

  • We recently demonstrated the anti-inflammatory properties of onion bulb extract (OBE) in reducing colitis severity in mice when administered at the same time of colitis induction

  • OBE can be used as an effective option in the prevention and/or the treatment of established colitis

Read more

Summary

Introduction

Inflammatory bowel disease (IBD) is a bacterially-triggered chronic inflammatory condition of the gastrointestinal tract in a genetically susceptible host [1,2,3,4]. The currently available pharmacological agents for disease management include corticosteroids (prednisolone, budesonide, etc.), immunosuppressants (cyclosporine, tacrolimus, methotrexate, 6-mercaptopurine), and biological-based therapies (infliximab, adalimumab, vedolozumab) Most of these agents have limitations in terms of severe adverse effect profile, high cost, and the development of dependence or resistance with chronic use [12,13,14,15,16]. The use of natural products has gained attraction recently in many disease conditions due to their efficacy and relatively acceptable side effect profile. (Family Amaryllidaceae) is considered one of the most commonly used medical plant species in traditional medicine in the management of various conditions including that of inflammatory nature such as asthma [21,22,23,24] and recently in IBD [25]. To test 1. whether OBE can reduce colitis severity when given either before (preventative approach) or after (treatment approach) colitis induction and if so, 2. what are the mechanisms by which onion can achieve these effects

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call